{"transactions":[{"id":739516,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:15:14.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":196299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":196299,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0001193125-26-269469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000119312526269469/ownership.xml","form_type":"4"}},{"id":739221,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:15:12.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":196299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":196299,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0001193125-26-269468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000119312526269468/ownership.xml","form_type":"4"}},{"id":739023,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38497,"kind":"person","name":"Averill Julianne","position":1,"cik":"0001903770","reported_name":"Averill Julianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:15:09.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":173711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":173711,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":173711},"source":{"system":"sec-edgar","filing":"0001193125-26-269465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000119312526269465/ownership.xml","form_type":"4"}},{"id":739234,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38574,"kind":"person","name":"Faust Elizabeth","position":1,"cik":"0001572143","reported_name":"Faust Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:15:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":196299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":196299,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0001193125-26-269470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572143/000119312526269470/ownership.xml","form_type":"4"}},{"id":816221,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:15:06.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":452512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":452512,"derivative":{"exercise_price":1.49,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":452512},"source":{"system":"sec-edgar","filing":"0001193125-26-142178","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526142178/ownership.xml","form_type":"4"}},{"id":815236,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:15:05.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":667477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":667477,"derivative":{"exercise_price":1.49,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":667477},"source":{"system":"sec-edgar","filing":"0001193125-26-142177","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000119312526142177/ownership.xml","form_type":"4"}},{"id":915928,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":915927,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":572427,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":915926,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":915925,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":622427,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":915924,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":true,"shares":50600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":915923,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-06T21:15:03.000Z","date":"2025-12-31","kind":"gift","planned":false,"acquired":false,"shares":50600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":672427,"source":{"system":"sec-edgar","filing":"0001193125-26-041207","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312526041207/ownership.xml","form_type":"5"}},{"id":969341,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-15T21:15:04.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.4333,"value":42999.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":723027,"source":{"system":"sec-edgar","filing":"0001193125-25-319222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312525319222/ownership.xml","form_type":"4"}},{"id":979877,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-12-04T21:15:03.000Z","date":"2025-12-02","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.9918,"value":99180.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9828 to $1.0099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001193125-25-308091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000119312525308091/ownership.xml","form_type":"4"}},{"id":983483,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-02T21:15:02.000Z","date":"2025-12-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.05,"value":10500.0,"ownership":{"direct":true},"balance_after":693027,"source":{"system":"sec-edgar","filing":"0001193125-25-305287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312525305287/ownership.xml","form_type":"4"}},{"id":983482,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-02T21:15:02.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":1.1013,"value":44052.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.09 to $1.1099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":683027,"source":{"system":"sec-edgar","filing":"0001193125-25-305287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000119312525305287/ownership.xml","form_type":"4"}},{"id":1067467,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T20:15:10.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":916434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":916434,"derivative":{"exercise_price":1.53,"expiration_date":"2035-08-10","underlying":"Common Stock","underlying_shares":916434},"source":{"system":"sec-edgar","filing":"0000950170-25-108045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017025108045/ownership.xml","form_type":"4"}},{"id":1067705,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T20:15:04.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":1246989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":1246989,"derivative":{"exercise_price":1.53,"expiration_date":"2035-08-10","underlying":"Common Stock","underlying_shares":1246989},"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067704,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067703,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":643027,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067702,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067701,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":653027,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067700,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":19400,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067699,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-31","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":663027,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1067698,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T20:15:04.000Z","date":"2025-01-28","kind":"gift","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":673027,"source":{"system":"sec-edgar","filing":"0000950170-25-108041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017025108041/ownership.xml","form_type":"4"}},{"id":1081809,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38497,"kind":"person","name":"Averill Julianne","position":1,"cik":"0001903770","reported_name":"Averill Julianne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-24T20:15:06.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":241177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the total number of shares subject to the stock option shall vest and become exercisable on each monthly anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":241177,"derivative":{"exercise_price":1.82,"expiration_date":"2035-07-21","underlying":"Common Stock","underlying_shares":241177},"source":{"system":"sec-edgar","filing":"0000950170-25-098343","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017025098343/ownership.xml","form_type":"4"}},{"id":1111346,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:15:18.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000950170-25-086191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017025086191/ownership.xml","form_type":"4"}},{"id":1111043,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:15:17.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000950170-25-086190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017025086190/ownership.xml","form_type":"4"}},{"id":1111890,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:02:39.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000929638-25-002234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825002234/form4.xml","form_type":"4"}},{"id":1111054,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38574,"kind":"person","name":"Faust Elizabeth","position":1,"cik":"0001572143","reported_name":"Faust Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:15:20.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000950170-25-086193","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572143/000095017025086193/ownership.xml","form_type":"4"}},{"id":1188620,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-28T20:15:03.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in twelve substantially equal monthly installments over a period of twelve months from March 25, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":350000,"derivative":{"exercise_price":2.52,"expiration_date":"2035-03-25","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000950170-25-046790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017025046790/ownership.xml","form_type":"4"}},{"id":1347212,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-02T16:30:08.000Z","date":"2024-11-30","kind":"grant","planned":false,"acquired":true,"shares":495,"price":6.154,"value":3046.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on November 29, 2024."}],"balance_after":42995,"source":{"system":"sec-edgar","filing":"0000950170-24-132253","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017024132253/ownership.xml","form_type":"4"}},{"id":1396416,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-01T20:30:12.000Z","date":"2024-09-30","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":10.06,"value":100600.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-24-110858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017024110858/ownership.xml","form_type":"4"}},{"id":1480847,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T20:38:16.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":51.025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000929638-24-002175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824002175/form4.xml","form_type":"4"}},{"id":1480238,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:30:16.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017024073075/ownership.xml","form_type":"4"}},{"id":1480127,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:30:08.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073069","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017024073069/ownership.xml","form_type":"4"}},{"id":1480404,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:30:07.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017024073068/ownership.xml","form_type":"4"}},{"id":1480249,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38574,"kind":"person","name":"Faust Elizabeth","position":1,"cik":"0001572143","reported_name":"Faust Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T16:30:14.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073074","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572143/000095017024073074/ownership.xml","form_type":"4"}},{"id":1481598,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":89986,"kind":"person","name":"Frias Juan Pablo","position":1,"cik":"0001990665","reported_name":"Frias Juan Pablo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-12T20:30:06.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":349,"price":8.942,"value":3120.758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on May 31, 2024."}],"balance_after":349,"source":{"system":"sec-edgar","filing":"0000950170-24-072493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017024072493/ownership.xml","form_type":"4"}},{"id":1482107,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-12T16:30:07.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":12509,"price":4.4257,"value":55361.0813,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.4199 to $4.4299, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":42500,"source":{"system":"sec-edgar","filing":"0000950170-24-072494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017024072494/ownership.xml","form_type":"4"}},{"id":1482106,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-12T16:30:07.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4448,"price":3.7825,"value":16824.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on June 1, 2022."}],"balance_after":29991,"source":{"system":"sec-edgar","filing":"0000950170-24-072494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017024072494/ownership.xml","form_type":"4"}},{"id":1675964,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":95071,"kind":"person","name":"Butler Thomas Andrew","position":1,"cik":"0001857171","reported_name":"Butler Thomas Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T21:30:18.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":407502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":407502,"derivative":{"exercise_price":14.44,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":407502},"source":{"system":"sec-edgar","filing":"0000950170-24-005417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017024005417/ownership.xml","form_type":"4"}},{"id":1676292,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T21:30:15.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":135700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":135700,"derivative":{"exercise_price":14.44,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":135700},"source":{"system":"sec-edgar","filing":"0000950170-24-005415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024005415/ownership.xml","form_type":"4"}},{"id":1675963,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":89986,"kind":"person","name":"Frias Juan Pablo","position":1,"cik":"0001990665","reported_name":"Frias Juan Pablo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T21:30:05.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":111090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":111090,"derivative":{"exercise_price":14.44,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":111090},"source":{"system":"sec-edgar","filing":"0000950170-24-005414","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017024005414/ownership.xml","form_type":"4"}},{"id":1676432,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T16:30:12.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":145245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":145245,"derivative":{"exercise_price":14.44,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":145245},"source":{"system":"sec-edgar","filing":"0000950170-24-005416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017024005416/ownership.xml","form_type":"4"}},{"id":1692126,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":713027,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692125,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692124,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":725027,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692123,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692122,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":728027,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692121,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":9400,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1692120,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-01-03T21:30:26.000Z","date":"2023-12-29","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":731027,"source":{"system":"sec-edgar","filing":"0000950170-24-000956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000095017024000956/ownership.xml","form_type":"4"}},{"id":1725528,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-01T17:58:08.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":1345,"price":3.7825,"value":5087.4625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on June 1, 2022."}],"balance_after":25543,"source":{"system":"sec-edgar","filing":"0000950170-23-067424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017023067424/ownership.xml","form_type":"4"}},{"id":1790402,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":89986,"kind":"person","name":"Frias Juan Pablo","position":1,"cik":"0001990665","reported_name":"Frias Juan Pablo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-01T21:10:37.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":16.87,"expiration_date":"2033-08-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-23-046099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017023046099/ownership.xml","form_type":"4"}},{"id":1851126,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:06:01.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028679","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000095017023028679/ownership.xml","form_type":"4"}},{"id":1852521,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:03:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000929638-23-001746","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963823001746/form4.xml","form_type":"4"}},{"id":1851854,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:00:48.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017023028668/ownership.xml","form_type":"4"}},{"id":1851417,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:00:48.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000095017023028670/ownership.xml","form_type":"4"}},{"id":1851438,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38574,"kind":"person","name":"Faust Elizabeth","position":1,"cik":"0001572143","reported_name":"Faust Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:02:37.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572143/000095017023028671/ownership.xml","form_type":"4"}},{"id":1868880,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T21:00:32.000Z","date":"2023-06-01","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":34.5633,"value":1728165.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02  Details of the specific transactions are available upon request."}],"balance_after":3500000,"source":{"system":"sec-edgar","filing":"0001859061-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000007/primary_doc.xml","form_type":"4"}},{"id":1868879,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T21:00:32.000Z","date":"2023-05-31","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":33.81,"value":2535750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43.  Details of the specific transactions are available upon request."}],"balance_after":3550000,"source":{"system":"sec-edgar","filing":"0001859061-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000007/primary_doc.xml","form_type":"4"}},{"id":1870004,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-02T17:01:14.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4273,"price":3.7825,"value":16162.6225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on June 1, 2022."}],"balance_after":24198,"source":{"system":"sec-edgar","filing":"0000950170-23-026142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000095017023026142/ownership.xml","form_type":"4"}},{"id":1888205,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T11:13:18.000Z","date":"2023-05-12","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":33.84,"value":846000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 25,000 shares were sold at an average price of 33.84 in multiple transactions in a range of 33.50 to 34.50.  Details of the specific transactions are available upon request."}],"balance_after":3625000,"source":{"system":"sec-edgar","filing":"0001859061-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000006/primary_doc.xml","form_type":"4"}},{"id":1897756,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T21:19:30.000Z","date":"2023-05-09","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":34.5048,"value":5175720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A total of 150,000 shares were sold at an average price of 34.508 in multiple transactions in a range of 33.61 to 35.64. Details of the specific transactions are available upon request."}],"balance_after":3650000,"source":{"system":"sec-edgar","filing":"0001859061-23-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000005/primary_doc.xml","form_type":"4"}},{"id":1897755,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-10T21:19:30.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":33.9931,"value":3399310.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 100,000 shares were sold at an average price of 33.9931 in multiple transactions in a range of 33.01 to 34.855. Details of the specific transactions are available upon request."}],"balance_after":3800000,"source":{"system":"sec-edgar","filing":"0001859061-23-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000005/primary_doc.xml","form_type":"4"}},{"id":1913100,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-26T12:36:59.000Z","date":"2023-04-20","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":29.1188,"value":5823760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 200,000 shares were sold at an average price of 29.1188 in multiple transactions in a range of 28.85 to 29.495.  Details of the specific transactions are available upon request"}],"balance_after":3900000,"source":{"system":"sec-edgar","filing":"0001859061-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000004/primary_doc.xml","form_type":"4"}},{"id":1923401,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-06T23:31:22.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":31.25,"value":6250000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64.  Additional details of the individual transactions are available upon request."}],"balance_after":4100000,"source":{"system":"sec-edgar","filing":"0001859061-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000003/primary_doc.xml","form_type":"4/A","original_submission_date":"2023-03-31"}},{"id":1923400,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-06T22:43:47.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":true,"shares":200000,"price":31.25,"value":6250000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"A total of 200,000 shares were sold at an average price of 31.25 in multiple transactions ranging in price from 30.87 to 31.64"}],"balance_after":4100000,"source":{"system":"sec-edgar","filing":"0001859061-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906123000002/primary_doc.xml","form_type":"4"}},{"id":1932582,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-04-03T20:30:25.000Z","date":"2023-03-30","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":30,"value":12000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (the \"Fund III\"), and a managed account (the \"Account\"). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Master Fund, Fund III, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (i) 1,795,928 shares of Common Stock held by the Master Fund, (ii) 1,717,232 shares of Common Stock held by Fund III, and (iii) 57,712 shares of Common Stock held by the Account."}],"balance_after":3570872,"source":{"system":"sec-edgar","filing":"0000929638-23-001057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963823001057/form4.xml","form_type":"4"}},{"id":2022569,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":734027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022568,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022567,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":804027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022566,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022565,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":808027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022564,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":6400,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022563,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-12-28","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":812027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022562,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-08-19","kind":"gift","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":816027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022561,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-08-16","kind":"gift","acquired":false,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":832027,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022560,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:20:15.000Z","date":"2022-07-01","kind":"gift","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 873,068 shares received prior to the gift in a distribution-in-kind, without consideration, from Biomea Health, LLC made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":849127,"source":{"system":"sec-edgar","filing":"0000899243-23-004578","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004578/doc5.xml","form_type":"5"}},{"id":2022559,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:10:15.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":3000,"price":17,"value":51000.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-23-004569","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004569/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-19"}},{"id":2022558,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:10:15.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":3000,"price":17,"value":51000.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-23-004569","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004569/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-19"}},{"id":2022557,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-02-10T21:10:15.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":2400,"price":17,"value":40800.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":2400,"source":{"system":"sec-edgar","filing":"0000899243-23-004569","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323004569/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-19"}},{"id":2057476,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53819,"kind":"person","name":"Erdtmann Rainer M","position":1,"cik":"0001455767","reported_name":"Erdtmann Rainer M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-10T22:00:43.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":118000,"derivative":{"exercise_price":7.05,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0000899243-23-001487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1455767/000089924323001487/doc4.xml","form_type":"4"}},{"id":2057173,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":95071,"kind":"person","name":"Butler Thomas Andrew","position":1,"cik":"0001857171","reported_name":"Butler Thomas Andrew","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-10T22:00:31.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":354350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":354350,"derivative":{"exercise_price":7.05,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":354350},"source":{"system":"sec-edgar","filing":"0000899243-23-001484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924323001484/doc4.xml","form_type":"4"}},{"id":2057528,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-10T17:00:42.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":126300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":126300,"derivative":{"exercise_price":7.05,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":126300},"source":{"system":"sec-edgar","filing":"0000899243-23-001486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000089924323001486/doc4.xml","form_type":"4"}},{"id":2098355,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-02T16:30:38.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":2518,"price":3.7825,"value":9524.335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on June 1, 2022."}],"balance_after":19925,"source":{"system":"sec-edgar","filing":"0000899243-22-037438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000089924322037438/doc4.xml","form_type":"4"}},{"id":2113981,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-16T21:30:14.000Z","date":"2022-11-14","kind":"purchase","acquired":true,"shares":5000,"price":7.93,"value":39650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $7.97, inclusive. The reporting person undertakes to provide to Biomea Fusion, Inc., any security holder of Biomea Fusion, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-22-036010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924322036010/doc4.xml","form_type":"4"}},{"id":2118005,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-14T16:30:51.000Z","date":"2022-11-11","kind":"purchase","acquired":true,"shares":4100,"price":7.6307,"value":31285.87,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $7.6000 to $7.6499, inclusive. The reporting person undertakes to provide to Biomea Fusion, Inc., any security holder of Biomea Fusion, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4."}],"balance_after":17407,"source":{"system":"sec-edgar","filing":"0000899243-22-035697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000089924322035697/doc4.xml","form_type":"4"}},{"id":2177797,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-19T10:56:16.000Z","date":"2022-08-16","kind":"purchase","acquired":false,"shares":30684,"price":13.872,"value":425648.448,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold in multiple transaction in a range of prices from 13.65 to 14.01 and an average price of 13.872.  Details of the specific trades are available upon request"}],"balance_after":4300000,"source":{"system":"sec-edgar","filing":"0001859061-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906122000002/primary_doc.xml","form_type":"4"}},{"id":2202538,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-25T23:16:25.000Z","date":"2022-07-21","kind":"sale","acquired":false,"shares":34658,"price":11.21,"value":388516.18,"ownership":{"direct":true},"balance_after":4330684,"source":{"system":"sec-edgar","filing":"0001859061-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185906122000001/primary_doc.xml","form_type":"4"}},{"id":2219925,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":112774,"kind":"organization","name":"A2A Pharmaceuticals, Inc.","position":1,"cik":"0001859061","reported_name":"A2A Pharmaceuticals, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T11:51:44.000Z","date":"2022-06-24","kind":"sale","acquired":false,"shares":34658,"price":11.76,"value":407578.08,"ownership":{"direct":true},"balance_after":4365342,"source":{"system":"sec-edgar","filing":"0001856641-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000185664122000001/primary_doc.xml","form_type":"4"}},{"id":2221803,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:15:58.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0000899243-22-024058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000089924322024058/doc4.xml","form_type":"4"}},{"id":2221716,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":53752,"kind":"person","name":"Hitchcock Michael J.M.","position":1,"cik":"0001856674","reported_name":"Hitchcock Michael J.M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:14:30.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0000899243-22-024056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924322024056/doc4.xml","form_type":"4"}},{"id":2221933,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:09:50.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0000899243-22-024053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322024053/doc4.xml","form_type":"4"}},{"id":2222156,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:00:39.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0001567619-22-013359","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000156761922013359/doc1.xml","form_type":"4"}},{"id":2221808,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":38574,"kind":"person","name":"Faust Elizabeth","position":1,"cik":"0001572143","reported_name":"Faust Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T17:07:20.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":45755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option shall vest in 36 equal monthly installments over a three year period beginning on June 22, 2022, so that all shares shall have vested on June 22, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":45755,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":45755},"source":{"system":"sec-edgar","filing":"0000899243-22-024051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572143/000089924322024051/doc4.xml","form_type":"4"}},{"id":2243493,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":126530,"kind":"organization","name":"Biomea Health, LLC","position":1,"cik":"0001856675","reported_name":"Biomea Health, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T22:29:36.000Z","date":"2022-06-01","kind":"other","acquired":false,"shares":4365342,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 1, 2022, Biomea Health, LLC distributed in-kind, without consideration, in the aggregate 4,365,342 shares of the Issuer's Common Stock pro-rata to its members, in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended. No shares were sold by the members."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 1, 2022, Biomea Health, LLC distributed in-kind, without consideration, in the aggregate 4,365,342 shares of the Issuer's Common Stock pro-rata to its members, in accordance with the exemption under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended. No shares were sold by the members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Biomea Health, LLC. Rainer M. Erdtmann and Thomas Butler are members of the Issuer's Board of Directors and members of the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-021082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840439/000089924322021082/doc4.xml","form_type":"4"}},{"id":2249585,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-01T18:00:14.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":3307,"price":4.6665,"value":15432.1155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the closing price of the Issuer's common stock on May 31, 2022."}],"balance_after":13307,"source":{"system":"sec-edgar","filing":"0000899243-22-020517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000089924322020517/doc4.xml","form_type":"4"}},{"id":2347124,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T00:00:12.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":21461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option shall vest in equal monthly installments over a three year period beginning on June 16, 2021, so that all shares shall have vested on June 16, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":21461,"derivative":{"exercise_price":5.9,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":21461},"source":{"system":"sec-edgar","filing":"0000899243-22-009752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000089924322009752/doc4.xml","form_type":"4"}},{"id":2433824,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":85546,"kind":"person","name":"Valle Franco","position":1,"cik":"0001699848","reported_name":"Valle Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-18T19:00:23.000Z","date":"2022-01-14","kind":"purchase","acquired":true,"shares":10000,"price":8.6767,"value":86767.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.5550 to $8.7400, inclusive. The reporting person undertakes to provide to Biomea Fusion, Inc., any security holder of Biomea Fusion, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-22-002217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699848/000089924322002217/doc4.xml","form_type":"4"}}],"next_cursor":"2022-01-18T19:00:23.000000Z,2433824"}